Time to deterioration of patient-reported outcome endpoints in cancer clinical trials: targeted literature review and best practice recommendations

Abstract Background Time to deterioration (TTD) endpoints are often utilized in the analysis of patient-reported outcome (PRO) data in oncology clinical trials but different endpoint definitions and analysis frameworks exist that can impact result interpretation. This review examined the analysis, r...

詳細記述

書誌詳細

主要な著者:	Kim Cocks, Bellinda L. King-Kallimanis, Joel Sims, Gill Worthy, Julia Stein, Lara Ayala–Nunes, Monika Achra, Zhanglin Lin Cui, Nalin Payakachat
フォーマット:	Artigo
言語:	Inglês
出版事項:	SpringerOpen 2024-12-01
シリーズ:	Journal of Patient-Reported Outcomes
主題:	Patient reported outcome Neoplasms Endpoint determination Survival analysis Randomized controlled trials Review literature
オンライン･アクセス:	https://doi.org/10.1186/s41687-024-00824-7
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!